Literature DB >> 23791887

Regulation and function of pyruvate kinase M2 in cancer.

Weiwei Yang1, Zhimin Lu.   

Abstract

Altered metabolism is fundamental to the growth and survival of cancer cells. Pyruvate kinase M2 (PKM2), a key enzyme in cancer metabolism, has been demonstrated to play a central role not only in metabolic reprogramming but also in direct regulation of gene expression and subsequent cell cycle progression. This review outlines the current understanding of PKM2 protein kinase activity and regulatory mechanisms underlying PKM2 expression, enzymatic activity, and nuclear localization, thus highlighting PKM2 as a potential therapeutic target.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Gene expression; PKM2; The Warburg effect

Mesh:

Substances:

Year:  2013        PMID: 23791887      PMCID: PMC3950276          DOI: 10.1016/j.canlet.2013.06.008

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  66 in total

1.  Shikonin and its analogs inhibit cancer cell glycolysis by targeting tumor pyruvate kinase-M2.

Authors:  J Chen; J Xie; Z Jiang; B Wang; Y Wang; X Hu
Journal:  Oncogene       Date:  2011-04-25       Impact factor: 9.867

2.  On the origin of cancer cells.

Authors:  O WARBURG
Journal:  Science       Date:  1956-02-24       Impact factor: 47.728

3.  Purification and properties of pyruvate kinase from human lung.

Authors:  E Corcoran; J J Phelan; P F Fottrell
Journal:  Biochim Biophys Acta       Date:  1976-09-28

4.  The L- and R-type isozymes of rat pyruvate kinase are produced from a single gene by use of different promoters.

Authors:  T Noguchi; K Yamada; H Inoue; T Matsuda; T Tanaka
Journal:  J Biol Chem       Date:  1987-10-15       Impact factor: 5.157

5.  Genes of glycolysis are ubiquitously overexpressed in 24 cancer classes.

Authors:  B Altenberg; K O Greulich
Journal:  Genomics       Date:  2004-12       Impact factor: 5.736

Review 6.  Why do cancers have high aerobic glycolysis?

Authors:  Robert A Gatenby; Robert J Gillies
Journal:  Nat Rev Cancer       Date:  2004-11       Impact factor: 60.716

Review 7.  Double role for pyruvate kinase type M2 in the expansion of phosphometabolite pools found in tumor cells.

Authors:  E Eigenbrodt; M Reinacher; U Scheefers-Borchel; H Scheefers; R Friis
Journal:  Crit Rev Oncog       Date:  1992

8.  SAICAR stimulates pyruvate kinase isoform M2 and promotes cancer cell survival in glucose-limited conditions.

Authors:  Kirstie E Keller; Irene S Tan; Young-Sam Lee
Journal:  Science       Date:  2012-10-18       Impact factor: 47.728

9.  Nonmetabolic functions of pyruvate kinase isoform M2 in controlling cell cycle progression and tumorigenesis.

Authors:  Zhimin Lu
Journal:  Chin J Cancer       Date:  2011-12-23

10.  Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis.

Authors:  Dimitrios Anastasiou; Yimin Yu; William J Israelsen; Jian-Kang Jiang; Matthew B Boxer; Bum Soo Hong; Wolfram Tempel; Svetoslav Dimov; Min Shen; Abhishek Jha; Hua Yang; Katherine R Mattaini; Christian M Metallo; Brian P Fiske; Kevin D Courtney; Scott Malstrom; Tahsin M Khan; Charles Kung; Amanda P Skoumbourdis; Henrike Veith; Noel Southall; Martin J Walsh; Kyle R Brimacombe; William Leister; Sophia Y Lunt; Zachary R Johnson; Katharine E Yen; Kaiko Kunii; Shawn M Davidson; Heather R Christofk; Christopher P Austin; James Inglese; Marian H Harris; John M Asara; Gregory Stephanopoulos; Francesco G Salituro; Shengfang Jin; Lenny Dang; Douglas S Auld; Hee-Won Park; Lewis C Cantley; Craig J Thomas; Matthew G Vander Heiden
Journal:  Nat Chem Biol       Date:  2012-10       Impact factor: 15.040

View more
  82 in total

1.  EGFRwt/vIII-PKM2-β-catenin cascade affects proliferation and chemo-sensitivity in head and neck squamous cell carcinoma.

Authors:  Chao Jing; Xin Qu; Zhaoqing Li; Chuanqiang Wu; Minghui Zhao; Yu Wang; Shanshan Sun; Shengchi Zhang; Jinliang Chen; Yu Qiao; Xiaomeng Hu; Xiaofeng Yao; Rui Jin; Xudong Wang; Lun Zhang; Xuan Zhou
Journal:  Am J Cancer Res       Date:  2017-12-01       Impact factor: 6.166

2.  HIF1 mediates a switch in pyruvate kinase isoforms after myocardial infarction.

Authors:  Allison Lesher Williams; Vedbar Khadka; Mingxin Tang; Abigail Avelar; Kathryn J Schunke; Mark Menor; Ralph V Shohet
Journal:  Physiol Genomics       Date:  2018-04-13       Impact factor: 3.107

Review 3.  How do glycolytic enzymes favour cancer cell proliferation by nonmetabolic functions?

Authors:  H Lincet; P Icard
Journal:  Oncogene       Date:  2014-09-29       Impact factor: 9.867

4.  Identification of a multienzyme complex for glucose metabolism in living cells.

Authors:  Casey L Kohnhorst; Minjoung Kyoung; Miji Jeon; Danielle L Schmitt; Erin L Kennedy; Julio Ramirez; Syrena M Bracey; Bao Tran Luu; Sarah J Russell; Songon An
Journal:  J Biol Chem       Date:  2017-04-19       Impact factor: 5.157

Review 5.  Pyruvate Kinase M2: a Metabolic Bug in Re-Wiring the Tumor Microenvironment.

Authors:  Mohd Rihan; Lakshmi Vineela Nalla; Anil Dharavath; Amit Shard; Kiran Kalia; Amit Khairnar
Journal:  Cancer Microenviron       Date:  2019-06-10

6.  EGFR phosphorylates FAM129B to promote Ras activation.

Authors:  Haitao Ji; Jong-Ho Lee; Yugang Wang; Yilin Pang; Tao Zhang; Yan Xia; Lianjin Zhong; Jianxin Lyu; Zhimin Lu
Journal:  Proc Natl Acad Sci U S A       Date:  2015-12-31       Impact factor: 11.205

7.  Extracellular PKM2 induces cancer proliferation by activating the EGFR signaling pathway.

Authors:  Ming-Chuan Hsu; Wen-Chun Hung; Hirohito Yamaguchi; Seung-Oe Lim; Hsin-Wei Liao; Chia-Hua Tsai; Mien-Chie Hung
Journal:  Am J Cancer Res       Date:  2016-02-15       Impact factor: 6.166

8.  Glycolysis regulated transglutaminase 2 activation in cardiopulmonary fibrogenic remodeling.

Authors:  Chinmayee D Bhedi; Sabina Nasirova; Deniz Toksoz; Rod R Warburton; Kevin J Morine; Navin K Kapur; Jonas B Galper; Ioana R Preston; Nicholas S Hill; Barry L Fanburg; Krishna C Penumatsa
Journal:  FASEB J       Date:  2019-11-28       Impact factor: 5.191

Review 9.  Revisiting the hallmarks of cancer.

Authors:  Yousef Ahmed Fouad; Carmen Aanei
Journal:  Am J Cancer Res       Date:  2017-05-01       Impact factor: 6.166

10.  MiR-338-3p targets pyruvate kinase M2 and affects cell proliferation and metabolism of ovarian cancer.

Authors:  Yuting Zhang; Bing Shi; Jiang Chen; Lina Hu; Chunquan Zhao
Journal:  Am J Transl Res       Date:  2016-07-15       Impact factor: 4.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.